BioCentury
ARTICLE | Clinical News

Adenovirus vector bearing cytosine deaminase gene for intra-tumor generation of the chemotherapy agent 5-fluorouracil: Received RAC approval to test the therapy

September 18, 1995 7:00 AM UTC

GenVec, Rockville, Md. Product: Adenovirus vector bearing cytosine deaminase gene for intra-tumor generation of the chemotherapy agent 5-fluorouracil (5-FU) Indication: Gene therapy for liver metastas...